Format
Sort by
Items per page

Send to

Choose Destination

Best matches for O’Brien EM[au]:

Search results

Items: 47

1.

The Cajal Body Protein WRAP53β Prepares the Scene for Repair of DNA Double-Strand Breaks by Regulating Local Ubiquitination.

Bergstrand S, O'Brien EM, Farnebo M.

Front Mol Biosci. 2019 Jul 4;6:51. doi: 10.3389/fmolb.2019.00051. eCollection 2019. Review.

2.

Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control.

Sanseviero E, O'Brien EM, Karras JR, Shabaneh TB, Aksoy BA, Xu W, Zheng C, Yin X, Xu X, Karakousis GC, Amaravadi RK, Nam B, Turk MJ, Hammerbacher J, Rubinstein MP, Schuchter LM, Mitchell TC, Liu Q, Stone EL.

Cancer Immunol Res. 2019 Aug;7(8):1371-1380. doi: 10.1158/2326-6066.CIR-18-0386. Epub 2019 Jun 25.

PMID:
31239316
3.

Sequential drug delivery to modulate macrophage behavior and enhance implant integration.

O'Brien EM, Risser GE, Spiller KL.

Adv Drug Deliv Rev. 2019 May 16. pii: S0169-409X(19)30055-9. doi: 10.1016/j.addr.2019.05.005. [Epub ahead of print]

PMID:
31103451
4.

Epicardial Cavernous Hemangioma: A Diagnostic Challenge.

O'Brien EM, Low YH.

CASE (Phila). 2018 Sep 22;2(6):262-265. doi: 10.1016/j.case.2018.07.004. eCollection 2018 Dec. No abstract available.

5.

Caring for adults with congenital heart disease in a regional setting.

O'Brien EM, Law D, Celermajer D, Grant PW, Waites J.

Aust J Rural Health. 2018 Dec;26(6):441-446. doi: 10.1111/ajr.12446. Epub 2018 Nov 19.

PMID:
30456832
6.

The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells.

O'Brien EM, Selfe JL, Martins AS, Walters ZS, Shipley JM.

BMC Cancer. 2018 Feb 21;18(1):217. doi: 10.1186/s12885-018-4129-8.

7.

Beliefs, Behaviors, and Contexts of Adolescent Caffeine Use: A Focus Group Study.

Ludden AB, O'Brien EM, Pasch KE.

Subst Use Misuse. 2017 Jul 29;52(9):1207-1218. doi: 10.1080/10826084.2017.1302957. Epub 2017 Jun 12.

PMID:
28605229
8.

Sleep duration and weight loss among overweight/obese women enrolled in a behavioral weight loss program.

O'Brien EM, Fava J, Subak LL, Stone K, Hart CN, Demos K, Wing R.

Nutr Diabetes. 2012 Sep 10;2:e43. doi: 10.1038/nutd.2012.17.

9.

Perylenequinones: Isolation, Synthesis, and Biological Activity.

Mulrooey CA, O'Brien EM, Morgan BJ, Kozlowski MC.

European J Org Chem. 2012 Jul 1;2012(21):3887-3904.

10.

Insomnia is associated with impaired quality of life among bariatric surgery candidates.

O'Brien EM, Dalrymple K, Hrabosky J, Chelminski I, Young D, Zimmerman M.

Obes Res Clin Pract. 2012 Apr-Jun;6(2):e91-e174. doi: 10.1016/j.orcp.2011.06.001.

PMID:
24331249
11.

Intraindividual variability in daily sleep and pain ratings among chronic pain patients: bidirectional association and the role of negative mood.

O'Brien EM, Waxenberg LB, Atchison JW, Gremillion HA, Staud RM, McCrae CS, Robinson ME.

Clin J Pain. 2011 Jun;27(5):425-33. doi: 10.1097/AJP.0b013e318208c8e4.

PMID:
21415723
12.

Severe insomnia is associated with more severe presentation and greater functional deficits in depression.

O'Brien EM, Chelminski I, Young D, Dalrymple K, Hrabosky J, Zimmerman M.

J Psychiatr Res. 2011 Aug;45(8):1101-5. doi: 10.1016/j.jpsychires.2011.01.010. Epub 2011 Feb 8.

PMID:
21306733
13.

A novel positioning technique for the agitated patient after electroconvulsive therapy: gravitational restraint.

O'Brien EM, Rosenquist PB, Kimball JN, Minor LN, Arias LM.

J ECT. 2010 Sep;26(3):158. doi: 10.1097/YCT.0b013e3181ec0d75.

PMID:
20805725
14.

Characterization of the apoptotic response of human leukemia cells to organosulfur compounds.

Wong WW, Boutros PC, Wasylishen AR, Guckert KD, O'Brien EM, Griffiths R, Martirosyan AR, Bros C, Jurisica I, Langler RF, Penn LZ.

BMC Cancer. 2010 Jul 2;10:351. doi: 10.1186/1471-2407-10-351.

15.

Negative mood mediates the effect of poor sleep on pain among chronic pain patients.

O'Brien EM, Waxenberg LB, Atchison JW, Gremillion HA, Staud RM, McCrae CS, Robinson ME.

Clin J Pain. 2010 May;26(4):310-9. doi: 10.1097/AJP.0b013e3181c328e9.

PMID:
20393266
16.

Tackling sleeplessness: psychological treatment options for insomnia in older adults.

Dzierzewski JM, O'Brien EM, Kay D, McCrae CS.

Nat Sci Sleep. 2010 Apr 1;2:47-61.

17.
18.

Perylenequinone natural products: total synthesis of hypocrellin A.

O'Brien EM, Morgan BJ, Mulrooney CA, Carroll PJ, Kozlowski MC.

J Org Chem. 2010 Jan 1;75(1):57-68. doi: 10.1021/jo901386d.

19.

Synthesis of the cores of hypocrellin and shiraiachrome: diastereoselective 1,8-diketone aldol cyclization.

O'Brien EM, Li J, Carroll PJ, Kozlowski MC.

J Org Chem. 2010 Jan 1;75(1):69-73. doi: 10.1021/jo9018914.

20.

Patient-centered perspective on treatment outcomes in chronic pain.

O'Brien EM, Staud RM, Hassinger AD, McCulloch RC, Craggs JG, Atchison JW, Price DD, Robinson ME.

Pain Med. 2010 Jan;11(1):6-15. doi: 10.1111/j.1526-4637.2009.00685.x. Epub 2009 Sep 1.

PMID:
19732374
21.

Dexmedetomidine and the successful management of electroconvulsive therapy postictal agitation: a case report.

O'Brien EM, Rosenquist PB, Kimball JN, Dunn GN, Smith B, Arias LM.

J ECT. 2010 Jun;26(2):131-3. doi: 10.1097/YCT.0b013e3181b07c26.

PMID:
19710618
22.

Dynamic stereochemistry transfer in a transannular aldol reaction: total synthesis of hypocrellin A.

O'Brien EM, Morgan BJ, Kozlowski MC.

Angew Chem Int Ed Engl. 2008;47(36):6877-80. doi: 10.1002/anie.200800734. No abstract available.

PMID:
18506776
23.

Development of a catalytic aromatic decarboxylation reaction.

Dickstein JS, Mulrooney CA, O'Brien EM, Morgan BJ, Kozlowski MC.

Org Lett. 2007 Jun 21;9(13):2441-4. Epub 2007 Jun 2.

PMID:
17542594
24.

Somatic focus/awareness: Relationship to negative affect and pain in chronic pain patients.

O'Brien EM, Atchison JW, Gremillion HA, Waxenberg LB, Robinson ME.

Eur J Pain. 2008 Jan;12(1):104-15. Epub 2007 May 23.

25.

Hormonal regulation of nuclear permeability.

O'Brien EM, Gomes DA, Sehgal S, Nathanson MH.

J Biol Chem. 2007 Feb 9;282(6):4210-7. Epub 2006 Dec 7.

26.

Sensitive topics, survey nonresponse, and considerations for interviewer training.

O'Brien EM, Black MC, Carley-Baxter LR, Simon TR.

Am J Prev Med. 2006 Nov;31(5):419-26. Epub 2006 Sep 25.

PMID:
17046414
27.

Optimization of thermocautery in excisional dermatologic surgery.

Lane JE, O'brien EM, Kent DE.

Dermatol Surg. 2006 May;32(5):669-75.

PMID:
16706762
28.

Sleep and risk-taking behavior in adolescents.

O'Brien EM, Mindell JA.

Behav Sleep Med. 2005;3(3):113-33.

PMID:
15984914
29.

Electronic control of chiral quaternary center creation in the intramolecular asymmetric heck reaction.

Busacca CA, Grossbach D, Campbell SJ, Dong Y, Eriksson MC, Harris RE, Jones PJ, Kim JY, Lorenz JC, McKellop KB, O'Brien EM, Qiu F, Simpson RD, Smith L, So RC, Spinelli EM, Vitous J, Zavattaro C.

J Org Chem. 2004 Aug 6;69(16):5187-95.

PMID:
15287760
30.
31.

Probing electronic effects in the asymmetric Heck reaction with the BIPI ligands.

Busacca CA, Grossbach D, So RC, O'Brien EM, Spinelli EM.

Org Lett. 2003 Feb 20;5(4):595-8. Erratum in: Org Lett. 2003 May 1;5(9):1595.

PMID:
12583778
32.

Incidence of intravascular penetration in transforaminal cervical epidural steroid injections.

Furman MB, Giovanniello MT, O'Brien EM.

Spine (Phila Pa 1976). 2003 Jan 1;28(1):21-5.

PMID:
12544950
33.

Incidence of intravascular penetration in transforaminal lumbosacral epidural steroid injections.

Furman MB, O'Brien EM, Zgleszewski TM.

Spine (Phila Pa 1976). 2000 Oct 15;25(20):2628-32.

PMID:
11034648
34.

Is it really possible to do a selective nerve root block?

Furman MB, O'Brien EM.

Pain. 2000 Apr;85(3):526. No abstract available.

PMID:
10866568
35.

Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.

O'Brien EM, Dostert P, Tipton KF.

Biochem Pharmacol. 1995 Jul 31;50(3):317-24.

PMID:
7646533
36.

Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase.

O'Brien EM, Dostert P, Pevarello P, Tipton KF.

Biochem Pharmacol. 1994 Aug 30;48(5):905-14.

PMID:
8093103
37.

The interactions of milacemide with monoamine oxidase.

O'Brien EM, Tipton KF, McCrodden JM, Youdim MB.

Biochem Pharmacol. 1994 Feb 11;47(4):617-23.

PMID:
8129740
38.

Inhibition of monoamine oxidase by clorgyline analogues.

O'Brien EM, Tipton KF, Meroni M, Dostert P.

J Neural Transm Suppl. 1994;41:295-305.

PMID:
7931241
39.

A discontinuous luminometric assay for monoamine oxidase.

O'Brien EM, Kiely KA, Tipton KF.

Biochem Pharmacol. 1993 Oct 5;46(7):1301-6.

PMID:
8216383
40.

The de-endothelialized rat carotid arterial graft: a versatile experimental model for the investigation of arterial thrombosis.

Cooley BC, Li X, Dzwierzynski W, Gruel SM, Hall RL, Wright RR, O'Brien EM, Fagan D, Hanel DP, Gould JS.

Thromb Res. 1992 Jul 1;67(1):1-14.

PMID:
1440509
41.

Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions?

O'Brien EM, Tipton KF, Strolin Benedetti M, Bonsignori A, Marrari P, Dostert P.

Biochem Pharmacol. 1991 Jun 1;41(11):1731-7.

PMID:
2043162
42.

Infant's apnea, bradycardia and tachycardia monitor based on the Z-80 microprocessor.

Liu S, O'Brien EM.

Comput Biol Med. 1987;17(4):269-77.

PMID:
3665454
44.

Resolution of the isoenzymes of soybean lipoxygenase using isoelectric focusing and chromatofocusing.

Funk MO, Whitney MA, Hausknecht EC, O'Brien EM.

Anal Biochem. 1985 Apr;146(1):246-51.

PMID:
2581473
45.

Initial treatment of profound accidental hypothermia.

Harnett RM, O'Brien EM, Sias FR, Pruitt JR.

Aviat Space Environ Med. 1980 Jul;51(7):680-7.

PMID:
7417132
46.

Letter: Success with lithium in a disturbed child.

Lena B, O'Brien EM.

Lancet. 1975 Dec 27;2(7948):1307-8. No abstract available.

PMID:
54827
47.

Studies on purified bovine spleen adenosine deaminase.

O'Brien EM, Tully ER.

Biochem J. 1968 Nov;110(2):17P. No abstract available.

Supplemental Content

Loading ...
Support Center